This molecule has been studied in serum or tumor tissues or tumor lines of several other tumors but there is little information about the levels of endocan in the brain tumors and the present study is the first prospective study to show expressions of endocan in patients with common brain tumors, namely, gliomas and meningiomas. Here, ESM1 is linked to meningioma.